Article Details

FDA Approves Expanded Indication of Eculizumab for Pediatric Generalized Myasthenia Gravis

Retrieved on: 2025-03-13 01:50:22

Tags for this article:

Click the tags to see associated articles and topics

FDA Approves Expanded Indication of Eculizumab for Pediatric Generalized Myasthenia Gravis. View article details on hiswai:

Excerpt

Eculizumab, a humanized monoclonal antibody, was first approved for adults with generalized myasthenia gravis in 2017.

Article found on: www.pharmacytimes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo